10-Q: AMN Healthcare Q3 Revenue Dips, Impairments Hit 9-Month Net Loss
Quarterly Report
AMN Healthcare reported an 8% revenue decline in Q3 2025, with significant goodwill and intangible asset impairments leading to a net loss for the nine months, despite a Q3 net income increase.
Summary
- Revenue for the three months ended September 30, 2025, decreased 8% to $634.5 million from $687.5 million in the same period of 2024.
- Revenue for the nine months ended September 30, 2025, decreased 12% to $1,982.2 million from $2,249.1 million in the same period of 2024.
- Net income for the three months ended September 30, 2025, increased to $29.3 million ($0.76 basic EPS) from $7.0 million ($0.18 basic EPS) in the prior year.
- Net loss for the nine months ended September 30, 2025, was $88.0 million ($(2.29) basic EPS), a significant decline from net income of $40.6 million ($1.06 basic EPS) in the same period of 2024.
- Gross profit for Q3 2025 decreased 13% to $184.4 million, with gross margin at 29.1% (down from 31.0% in Q3 2024).
- Gross profit for the nine months ended September 30, 2025, decreased 17% to $578.9 million, with gross margin at 29.2% (down from 31.1% in the prior year).
- A goodwill impairment loss of $109.5 million was recognized in the Physician and Leadership Solutions segment during the nine months ended September 30, 2025.
- An impairment loss of $18.3 million was recognized for customer relationships intangible assets in the Nurse and Allied Solutions segment during the nine months ended September 30, 2025.
- The sale of Smart Square healthcare scheduling software on July 1, 2025, generated $65.3 million in cash and a $10.0 million promissory note, resulting in a preliminary gain of $39.2 million.
- Net cash provided by operating activities for the nine months ended September 30, 2025, was $193.9 million, down from $247.6 million in the prior year.
Sentiment
Score: 3
Explanation: While Q3 net income showed a positive swing, the overall nine-month performance is significantly negative due to substantial revenue declines across segments and large impairment charges. The debt refinancing is a positive step for liquidity management, but the underlying operational challenges and market pressures remain concerning.
Positives
- Net income for the three months ended September 30, 2025, increased to $29.3 million from $7.0 million in the prior year.
- Basic EPS for Q3 2025 increased to $0.76 from $0.18 in Q3 2024.
- A preliminary gain on sale of the Smart Square disposal group of $39.2 million was recognized in Q3 2025.
- Interest expense, net, and other decreased to $9.6 million in Q3 2025 from $14.4 million in Q3 2024, and to $33.3 million for the nine months from $46.8 million in the prior year, due to a lower average debt outstanding balance.
- Labor disruption revenue increased by $12.0 million in Q3 2025 and $66.0 million for the nine months ended September 30, 2025.
- Locum tenens business revenue increased by $4.0 million (3%) in Q3 2025 due to an 8% increase in revenue per day filled.
- Demand for permanent search services was positive compared to prior year and prior quarter in Q3 2025.
- Demand for interim leadership increased by double digits compared to prior year in Q3 2025.
- Language services minute volume grew compared to both the previous year and quarter in Q3 2025.
- Post-quarter end, the company successfully refinanced debt by issuing $400.0 million 6.500% senior notes due 2031 and redeeming $500.0 million 4.625% senior notes due 2027, extending maturity and revising leverage ratio covenants.
Negatives
- Revenue decreased 8% in Q3 2025 and 12% for the nine months ended September 30, 2025, across all segments, with the greatest decline in nurse and allied solutions.
- A net loss of $88.0 million was reported for the nine months ended September 30, 2025, compared to net income of $40.6 million in the prior year.
- A goodwill impairment loss of $109.5 million was recognized in the Physician and Leadership Solutions segment for the nine months ended September 30, 2025.
- A long-lived assets impairment loss of $18.3 million was recognized for customer relationships intangible assets in the Nurse and Allied Solutions segment for the nine months ended September 30, 2025.
- Consolidated gross margin declined to 29.1% in Q3 2025 (from 31.0%) and 29.2% for the nine months (from 31.1%).
- Nurse and allied solutions segment revenue decreased 9% in Q3 2025 and 15% for the nine months, primarily due to an 11% decrease in average travelers on assignment in Q3 and a 16% decrease for the nine months.
- Physician and leadership solutions segment revenue decreased 1% in Q3 2025 and 5% for the nine months, with declines in interim leadership, physician permanent placement, and executive search businesses.
- Technology and workforce solutions segment revenue decreased 12% in Q3 2025 and 10% for the nine months, primarily due to declines in VMS and other solutions businesses.
- VMS business revenue declined $8.1 million (32%) in Q3 2025 and $26.3 million (32%) for the nine months due to lower staffing volumes and prior client losses.
- Pricing pressure for language services is expected due to increased market competition.
- Net cash provided by operating activities decreased by $53.7 million for the nine months ended September 30, 2025, compared to the prior year.
Risks
- The ability of clients to increase the efficiency and effectiveness of their staffing management and recruiting efforts, through predictive analytics, automation, machine learning, artificial intelligence (AI) or other advanced technologies or otherwise, and successfully hire and retain permanent staff, which may negatively affect revenue, results of operations, and cash flows.
- The effects of economic downturns, inflation, recession or slow recoveries, or additional changes in or continued uncertainty with respect to governmental policies, which could result in less demand for services, increased client initiatives designed to contain costs, including reevaluating their approach as it pertains to contingent labor and managed services programs.
- Any inability to anticipate and quickly respond to changing marketplace conditions, such as alternative modes of healthcare delivery, reimbursement, or client needs and requirements.
- The level of consolidation and concentration of buyers of healthcare workforce, staffing and technology solutions, which could affect the pricing of services and the ability to mitigate concentration risk.
- The negative effects that intermediary organizations may have on the ability to secure new and profitable contracts.
- A decline in the size of the insured population as a result of a repeal or significant erosion of the Patient Protection and Affordable Care Act.
- The effect of investigations, claims, and legal proceedings alleging medical malpractice, anti-competitive conduct, violations of employment, privacy and wage regulations and other legal theories of liability asserted against the company, which could subject it to substantial liabilities.
- Any inability to grow and operate the business profitably in compliance with federal and state regulation, including privacy laws, conduct of operations, costs and payment for services and payment for referrals as well as laws regarding employment and compensation practices and government contracting.
- Changes in United States immigration laws and policies, including those relating to workers from outside the United States and visa retrogression.
- Any challenge to the classification of certain healthcare professionals as independent contractors, which could adversely affect profitability.
- Any inability to recruit and retain sufficient quality healthcare professionals at reasonable costs, which could increase operating costs and negatively affect business and profitability.
- Any technology disruptions or inability to implement new infrastructure and technology systems effectively may adversely affect operating results and ability to manage the business effectively.
- Any failure to further develop and evolve current workforce solutions technology offerings and capabilities, an increase in competition, or the ability of competitors to respond more quickly to new or emerging client needs and marketplace conditions, which may harm the business and/or impact the ability to compete.
- Disruption to or failures of SaaS-based or technology-enabled services, or inability to adequately protect intellectual property rights with respect to such technologies or sufficiently protect the privacy of personal information, could reduce client satisfaction, harm reputation and negatively affect the business.
- Security breaches and cybersecurity incidents, including ransomware, that could compromise information and systems, which could adversely affect business operations and reputation and could subject the company to substantial liabilities.
- Widespread use of AI.
- Any inability to quickly and properly credential and match quality healthcare professionals with suitable placements, which may adversely affect demand for services.
- Any inability to continue to attract, develop and retain sales and operations team members, which may deteriorate operations.
- Increasing dependence on third parties, including offshore vendors, for the execution of certain critical functions.
- The loss of key officers and management personnel, which could adversely affect business and operating results.
- Any inability to maintain positive brand awareness and identity, which may adversely affect results of operations.
- Any inability to consummate and effectively incorporate acquisitions into business operations, which may adversely affect long-term growth and results of operations.
- Businesses acquired may have liabilities or adverse operating issues, which could harm operating results.
- Any increase to business and operating risks as new services and clients are developed, new lines of business are entered, and more business is focused on providing a full range of client solutions.
- The expansion of social media platforms presents new risks and challenges, which could cause damage to brand reputation.
- Any recognition of an impairment to the substantial amount of goodwill or intangible assets on the balance sheet, which could result in a material adverse impact to results of operations.
- Indebtedness, which could adversely affect the ability to raise additional capital to fund operations, limit the ability to react to changes in the economy or industry, and expose the company to interest rate risk to the extent of any variable rate debt.
- The terms of debt instruments that impose restrictions that may affect the ability to successfully operate the business.
- Variable rate indebtedness.
- The effect of significant adverse adjustments to insurance-related accruals on the balance sheet, which could decrease earnings or increase losses and negatively impact cash flows.
Future Outlook
The company anticipates ongoing pricing pressure for language services due to increased market competition. Management believes that cash generated from operations and available borrowings under the Senior Credit Facility will be sufficient to fund operations and liquidity requirements for the next 12 months and beyond. The estimated annual effective tax rate for 2025 is approximately 9%.
Management Comments
- "After the COVID-19 pandemic subsided, healthcare organizations began focusing on hiring permanent staff, implementing cost management strategies, and exploring alternative staffing models to decrease reliance on contingent labor."
- "Uncertainty about government policy impacts appeared to place the healthcare sector in a more conservative stance with travel nurse demand declining compared with the first quarter."
- "In our travel nurse business, demand increased in the third quarter compared to the second quarter with strong winter orders but overall remained slightly below prior year."
- "In allied staffing, our demand continued to surpass pre-pandemic levels although demand is lower than prior quarter and in line with prior year."
- "Average international nurse staffing volume reached a low point early in the third quarter and grew through the end of the quarter, although volume remained lower than both prior quarter and prior year."
- "Overall, bill rates in the third quarter were relatively flat to the prior quarter."
- "Third quarter demand for locum tenens staffing was down year over year but grew in the mid-single digits compared to the previous quarter."
- "Certified registered nurse anesthetists (CRNAs) remain our largest locum tenens specialty."
- "Demand for permanent search services was positive compared to prior year and prior quarter."
- "Demand for interim leadership increased by double digits compared to prior year but was down quarter over quarter."
- "Third quarter minute volume in the language services business grew compared to both the previous year and quarter, but at a slower pace than prior years."
- "Volumes in our VMS business declined both sequentially and compared to prior year primarily due to lower staffing volume levels and the delayed impact from prior period client losses."
Industry Context
The healthcare industry is shifting post-COVID-19, with organizations prioritizing permanent staff hiring, cost management, and alternative staffing models to reduce reliance on contingent labor. This trend is impacting demand for travel nurses and VMS solutions. While some areas like labor disruption services and permanent search show growth, overall staffing volumes are experiencing declines and pricing pressures due to increased competition and a more conservative stance in the healthcare sector.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Credit Agreement Amendment | Fifth Amendment to the credit agreement on October 6, 2025, extended the maturity date of the Senior Credit Facility to October 6, 2030, decreased revolving commitments to $450.0 million, and revised the Consolidated Net Leverage Ratio covenant to be no greater than 5.25 to 1.00 through March 31, 2027. | 2025-10-06 | Improves long-term liquidity and financial flexibility by extending debt maturity and adjusting leverage covenants, but also reduces available revolving credit. |
Legal Proceedings
- The company is involved in various lawsuits, claims, investigations, and proceedings in the ordinary course of business, typically related to professional liability, tax, compensation, contract, competitor disputes, and employee-related matters.
- Significant matters include class and representative actions related to wage and hour claims under California and Federal law.
- The company accrues for contingencies when an adverse outcome is probable and estimable, reviewing at least quarterly.
Stakeholder Impact
- Shareholders: Negative impact from significant net loss for the nine months and impairment charges, offset by a positive Q3 net income and strategic debt refinancing. Share repurchase program remains authorized but no activity in the period.
- Employees (Healthcare Professionals): Decreased demand for travel nurses and interim leadership may affect assignment availability and pay packages. Increased provider pay packages contributed to lower gross margins.
- Customers (Healthcare Organizations): Continued focus on cost management and permanent hiring, potentially reducing reliance on the company's contingent labor services. Pricing pressure in language services due to market competition.
- Creditors: Debt refinancing extends maturities and adjusts covenants, potentially improving the company's ability to manage its debt obligations.
Next Steps
- Final working capital settlement for the Smart Square sale expected in the fourth quarter of 2025.
- Interest on the newly issued 2031 Notes will commence July 15, 2026, payable semi-annually.
- The company is evaluating the impact of adopting ASU 2023-09 (Income Taxes) on its disclosures for fiscal years beginning after December 15, 2024.
- The company is evaluating the impact of adopting ASU 2024-03 (Income Statement Expenses) on its disclosures for fiscal years beginning after December 15, 2026.
Key Dates
| Date | Description |
|---|---|
| 2023-11-01 | Board authorized share repurchase program of up to $150.0 million. |
| 2023-11-10 | Announced increase to share repurchase program. |
| 2024-02-16 | Announced increase to share repurchase program. |
| 2024-02-17 | Announced increase to share repurchase program. |
| 2024-06-15 | Announced increase to share repurchase program. |
| 2024-11-05 | Entered into the fourth amendment to credit agreement, increasing consolidated net leverage ratio covenant for year ending December 31, 2025. |
| 2024-12-15 | Effective date for ASU 2023-07 (Segment Reporting) for fiscal years beginning after this date. |
| 2025-01-01 | Effective date for certain provisions of the One Big Beautiful Bill Act (OBBBA). |
| 2025-01-01 | Effective date for ASU 2023-09 (Income Taxes) for fiscal years beginning after this date. |
| 2025-07-01 | Completed the sale of Smart Square healthcare scheduling software. |
| 2025-07-04 | The One Big Beautiful Bill Act (OBBBA) was enacted in the U.S. |
| 2025-09-30 | End of the quarterly reporting period. |
| 2025-10-06 | Completed the issuance of $400.0 million aggregate principal amount of 6.500% senior notes due 2031. |
| 2025-10-06 | Entered into the fifth amendment to its credit agreement, extending maturity of Senior Credit Facility to October 6, 2030, decreasing revolving commitments to $450.0 million, and revising Consolidated Net Leverage Ratio covenant. |
| 2025-10-15 | Earliest optional redemption date for 2031 Notes at specified prices. |
| 2025-10-22 | Redeemed the entire outstanding $500.0 million aggregate principal amount of the 2027 Notes. |
| 2025-11-04 | Number of common shares outstanding was 38,413,780. |
| 2025-11-06 | Date of filing of the 10-Q report. |
| 2026-07-15 | Commencement of semi-annual interest payments for the 2031 Notes. |
| 2026-12-15 | Effective date for ASU 2024-03 (Income Statement Expenses) for fiscal years beginning after this date. |
| 2027-01-01 | Payment due date for the $10.0 million 2027 Note Receivable from Smart Square sale. |
| 2027-03-31 | Consolidated Net Leverage Ratio covenant to be no greater than 5.25 to 1.00 through this date. |
| 2027-10-15 | Earliest optional redemption date for 2031 Notes at 103.250% of principal amount. |
| 2028-10-15 | Optional redemption date for 2031 Notes at 101.625% of principal amount. |
| 2029-10-15 | Optional redemption date for 2031 Notes at 100.000% of principal amount. |
| 2030-10-06 | Extended maturity date of the Senior Credit Facility. |
| 2031-01-15 | Maturity date of the 6.500% senior notes due 2031. |
Recommendation
holdThe company faces significant headwinds with declining revenue across its core segments and substantial impairment charges leading to a nine-month net loss. While the third quarter showed a return to profitability and the recent debt refinancing improves the capital structure, the underlying market trends of healthcare organizations reducing reliance on contingent labor and increasing pricing pressure are concerning. The stock may be oversold given the Q3 net income, but the long-term outlook remains challenged by industry shifts. A 'hold' recommendation is appropriate as investors should monitor if the company can stabilize revenue and improve margins in the face of these structural changes, and if the strategic debt management can provide a foundation for future recovery.
Keywords
Healthcare Staffing, Nurse Staffing, Allied Staffing, Physician Staffing, Locum Tenens, Workforce Solutions, Vendor Management Systems, VMS, Healthcare Technology, Talent Acquisition, SEC Filing, 10-Q, Financial Results, Goodwill Impairment, Revenue Decline, Net Loss, Debt Refinancing, Healthcare Industry, Labor Disruption Services, Interim Leadership, Permanent Placement
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.